Biohaven Share Price

Biohaven Share Price

NYSE: BHVN | Small Cap | Healthcare
$12.38
-$1.29 (-9.47%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Biohaven Stock Performance

Open
$13.47
Prev. Close
$13.68
Circuit Range
N/A
Day Range
$12.31 - $13.65
Year Range
$8.04 - $18.23
Volume
1,69,723
Average Traded
$12.68

Biohaven Share Price Today

As of 21 November 2026, Biohaven Ltd.'s share price is $12.38. The stock opened at $13.47, compared to its previous close of $13.68. During today's trading session, Biohaven Ltd.'s share price traded between $12.31 and $13.65, with an average price of $12.98. Over the past 52 weeks, the stock has recorded a high of $18.23 and a low of $8.04. In terms of performance, Biohaven Ltd.'s share price has risen by 12.39% over the last six months and is up 23.55% on a year-on-year basis.

Biohaven Share Price Chart

Line chart of the Biohaven price trend over the selected period. The price fell overall, ranging from 12.34 to 13.69, ending at 12.38.
$12.31$13.65
L
Show Current Price
H

Biohaven Stock Fundamentals & Key Indicators

Market Cap
$1.33B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.59
Revenue (TTM)
$0.00
Return On Equity (TTM)
552.36%
Profit Margin
N/A
Debt to Equity
-2.69
Quarterly Earnings Growth YoY
11.18%

Biohaven Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$145.56-$130.53-$137.31-$129.28
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A10.33%-5.19%5.85%

Biohaven Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$570.28-$408.17-$846.42-$738.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A28.43%-107.37%12.71%

Biohaven Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets83.1276.6470.7774.82
Current Assets368.33538.47442.45586.97
Total Assets451.45615.11513.21661.78
Non Current Liabilities283.4437.4529.8132.99
Current Liabilities115.93154.2355.4290.02
Total Liabilities399.38191.6785.24123.01
Shareholders' Equity52.07423.44427.98538.77

Biohaven Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-609.44-582.45-331.73-297.69
Investing300.56-244.97129.83-304.79
Financing439.12677.77211.91767.6

About Biohaven

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Biohaven Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$15.75
$12.34
-19.95%
Oct 2026
$13.30
$15.41
+15.21%
Sep 2026
$15.28
$13.38
-17.00%
Aug 2026
$13.33
$16.12
+19.50%
Jul 2026
$15.09
$13.49
-9.25%
Jun 2026
$11.04
$14.87
+34.95%
May 2026
$9.70
$11.02
+14.86%
Apr 2026
$8.50
$9.59
+13.49%
Mar 2026
$11.34
$8.45
-26.65%
Feb 2026
$11.57
$11.52
-2.74%
Jan 2026
$11.37
$11.85
+5.01%
Dec 2025
$9.76
$11.28
+12.57%

Biohaven Share Price FAQs